Claire Bradley

Claire Bradley

Auto-generated profile, based on publicly available information

Claire Bradley

Queensland Brain Institute, The University of Queensland, Australia

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 May 2022 in Nature Reviews Neuroscience
Verified
Journal Article
Closed access
PDF file
CBClaire Bradley
Claire Bradley
ANAbbey S. Nydam
Abbey S. Nydam
PDPaul E. Dux
Paul E. Dux
JMJason B. Mattingley
Jason B. Mattingley

20 November 2019 in Pain
Verified
Journal Article
Closed access
CQCharles Quesada
Charles Quesada
BPBenjamin Pommier
Benjamin Pommier
CFCamille Fauchon
Camille Fauchon
CBClaire Bradley
Claire Bradley
CCChristelle Créac'H
Christelle Créac'H
RPRoland Peyron
Roland Peyron
Repetitive transcranial magnetic stimulation (rTMS) is a procedure increasingly used to treat patients with central neuropathic pain, but its efficacy is still under debate. Patients with medically refractory chronic central neuropathic pain were included in 2 randomized phases (active/sham), separated by a wash-out period of 8 weeks. Each phase consisted of 4 consecutive rTMS sessions and a final evaluation session, all separated from one another by 3 weeks. High-frequency (20 Hz) rTMS was delivered over the primary motor cortex (M1) contralateral to the patient's pain using a neuronavigated robotic system. Patients and clinicians assessing outcomes were blinded to treatment allocation during the trial. The primary outcome measured the percentage of pain relief (%R) from baseline. Secondary outcomes were VAS score, Neuropathic Pain Symptom Inventory, analgesic drug consumption, and quality of life (EQ-5D). Thirty-six patients performed the entire study with no adverse effects. The analgesic effect for the main criterion (%R) was significantly higher in the active (33.8% confidence interval [CI]: [23.88-43.74]) than in the sham phase (13.02% CI: [6.64-19.76]). This was also the case for the secondary outcome VAS (−19.34% CI: [14.31-25.27] vs −4.83% CI: [1.96-8.18]). No difference was observed for quality of life or analgesic drug consumption. Seventeen patients (47%) were identified as responders, but no significant interaction was found between clinical and technical factors considered here and the analgesic response. These results provide strong evidence that 3 weeks spaced high-frequency rTMS of M1 results in a sustained analgesic effect and support the clinical interest of this stimulation paradigm to treat refractory chronic pain.

1 November 2018 in Archives of Physical Medicine and Rehabilitation
Verified
Journal Article
Closed access
CQCharles Quesada
Charles Quesada
BPBenjamin Pommier
Benjamin Pommier
CFCamille Fauchon
Camille Fauchon
CBClaire Bradley
Claire Bradley
CCChristelle Créac’h
Christelle Créac’h
RPRoland Peyron
Roland Peyron

1 January 2012 in Frontiers in Psychology
Verified
Journal Article
Open access
PDF file
CBClaire Bradley
Claire Bradley
JPJoel Pearson
Joel Pearson
Early visual memory can be split into two primary components: a high-capacity, short-lived iconic memory followed by a limited-capacity visual working memory that can last many seconds. Whereas a large number of studies have investigated visual working memory for low-level sensory features, much research on iconic memory has used more “high-level” alphanumeric stimuli such as letters or numbers. These two forms of memory are typically examined separately, despite an intrinsic overlap in their characteristics. Here, we used a purely sensory paradigm to examine visual short-term memory for 10 homogeneous items of three different visual features (color, orientation and motion) across a range of durations from 0 to 6 s. We found that the amount of information stored in iconic memory is smaller for motion than for color or orientation. Performance declined exponentially with longer storage durations and reached chance levels after ∼2 s. Further experiments showed that performance for the 10 items at 1 s was contingent on unperturbed attentional resources. In addition, for orientation stimuli, performance was contingent on the location of stimuli in the visual field, especially for short cue delays. Overall, our results suggest a smooth transition between an automatic, high-capacity, feature-specific sensory-iconic memory, and an effortful “lower-capacity” visual working memory.

23 September 2021 in Pain
Verified
Journal Article
Closed access
NSNoelia Samartin-Veiga
Noelia Samartin-Veiga
MPMarina Pidal-Miranda
Marina Pidal-Miranda
AGAlberto J. González-Villar
Alberto J. González-Villar
CBClaire Bradley
Claire Bradley
LGLuis Garcia-Larrea
Luis Garcia-Larrea
MCMaría T. Carrillo-De-La-Peña
María T. Carrillo-De-La-Peña
Transcranial direct current stimulation (tDCS) over the primary motor cortex (M1) and the dorsolateral prefrontal cortex seem to improve pain and other symptoms of fibromyalgia (FM), although the evidence on the effectiveness of tDCS and the optimal stimulation target is not robust enough. Our main objective was to establish the optimal area of stimulation, comparing the 2 classical targets and a novel pain-related area, the operculo-insular cortex, in a sham-controlled trial. Using a double-blind design, we randomly assigned 130 women with FM to 4 treatment groups (M1, dorsolateral prefrontal cortex, operculo-insular cortex, and sham), each receiving fifteen 20-minute sessions of 2 mA anodal tDCS over the left hemisphere. Our primary outcome was pain intensity. The secondary outcomes were the other core symptoms of FM (fatigue, mood, cognitive and sleep disorders, and hyperalgesia measured by the pressure pain threshold). We performed the assessment at 3 time points (before, immediately after treatment, and at 6 months follow-up). The linear mixed-model analysis of variances showed significant treatment effects across time for clinical pain and for fatigue, cognitive and sleep disturbances, and experimental pain, irrespective of the group. In mood, the 3 active tDCS groups showed a significantly larger improvement in anxiety and depression than sham. Our findings provide evidence of a placebo effect, support the use of tDCS for the treatment of affective symptoms, and challenge the effectiveness of tDCS as treatment of FM.

29 October 2014 in Brain Structure and Function
Verified
Journal Article
Closed access
PDF file
CBClaire Bradley
Claire Bradley
NJNiamh Joyce
Niamh Joyce
LGLuis Garcia-Larrea
Luis Garcia-Larrea